BioStock: Curasight carries out the first step of capitalization

In late June, Curasight announced a capital raise package of up to DKK 120 million to finance the ongoing development of its theranostic platform. Investment firm Fenja Capital II is honoring its pre-subscription obligations by subscribing for approximately a third of the units offered through the two unit issues. The total capitalization will fund important inflection points within the coming year.

Read the full article at biostock.se:

https://www.biostock.se/en/2024/09/curasight-carries-out-the-first-step-of-capitalization/

This is a press release from BioStock - Connecting Innovation & Capital. https://www.biostock.se